These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16014059)

  • 1. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy.
    Tang S; Leung JC; Chan LY; Lui YH; Tang CS; Kan CH; Ho YW; Lai KN
    Kidney Int; 2005 Aug; 68(2):802-12. PubMed ID: 16014059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
    Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
    Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R; Wu W; Wen Y; Li X
    Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term study of mycophenolate mofetil treatment in IgA nephropathy.
    Tang SC; Tang AW; Wong SS; Leung JC; Ho YW; Lai KN
    Kidney Int; 2010 Mar; 77(6):543-9. PubMed ID: 20032964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial.
    Frisch G; Lin J; Rosenstock J; Markowitz G; D'Agati V; Radhakrishnan J; Preddie D; Crew J; Valeri A; Appel G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2139-45. PubMed ID: 16030050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.
    Maes BD; Oyen R; Claes K; Evenepoel P; Kuypers D; Vanwalleghem J; Van Damme B; Vanrenterghem YF
    Kidney Int; 2004 May; 65(5):1842-9. PubMed ID: 15086925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil.
    Chen Z; Chen W; Zheng L; Xie Y; Yao K; Zhou T
    Curr Pharm Des; 2024; 30(30):2400-2409. PubMed ID: 38988169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N;
    JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate Mofetil: A Possible Alternative Treatment for IgA Nephropathy.
    Baraldi O; Comai G; Cuna V; Cappuccilli M; Serra C; Ronco C; La Manna G
    Contrib Nephrol; 2017; 190():108-116. PubMed ID: 28535523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
    Frutos MA; López V; Alférez MJ; Aranda P
    Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review.
    Tan CH; Loh PT; Yang WS; Chan CM
    Singapore Med J; 2008 Oct; 49(10):780-5. PubMed ID: 18946610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616].
    Hogg RJ; Wyatt RJ;
    BMC Nephrol; 2004 Mar; 5():3. PubMed ID: 15043759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
    Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.
    Segarra A; Amoedo ML; Martinez Garcia JM; Pons S; Praga M; Garcia EI; Alonso JC; Gascó JM; Pou L; Piera L
    Nephrol Dial Transplant; 2007 May; 22(5):1351-60. PubMed ID: 17311833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
    Xu G; Tu W; Jiang D; Xu C
    Am J Nephrol; 2009; 29(5):362-7. PubMed ID: 18974636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review.
    Chen Y; Li Y; Yang S; Li Y; Liang M
    BMC Nephrol; 2014 Dec; 15():193. PubMed ID: 25475967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.
    Roccatello D; Rossi D; Marletto F; Naretto C; Sciascia S; Baldovino S; Piras D; Giachino O
    J Nephrol; 2012; 25(2):198-203. PubMed ID: 21725921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
    Kawamura T
    Contrib Nephrol; 2007; 157():37-43. PubMed ID: 17495435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.